title: Progress and challenges in childhood tuberculosis.
authors.affiliation: Sydney Emerging Infections and Biosecurity Institute, and The Children's Hospital at Westmead, University of Sydney, Locked Bag 4001, Sydney, NSW 2145, Australia. ben.marais@health.nsw.gov.au
authors.forename: Ben J
authors.initials: BJ
authors.lastname: Marais
authors.forename: Stephen M
authors.initials: SM
authors.lastname: Graham
authors.forename: Markus
authors.initials: M
authors.lastname: Maeurer
authors.forename: Alimuddin
authors.initials: A
authors.lastname: Zumla
mesh_terms: D017088:AIDS-Related Opportunistic Infections / Q000382:microbiology; D000293:Adolescent; D000995:Antitubercular Agents / Q000627:therapeutic use; D001500:BCG Vaccine / Q000008:administration & dosage*; D002648:Child; D002675:Child, Preschool; D004198:Disease Susceptibility; D006801:Humans; D007113:Immunity, Innate; D007538:Isoniazid / Q000627:therapeutic use; D009169:Mycobacterium tuberculosis / Q000276:immunology / Q000302:isolation & purification; D012293:Rifampin / Q000627:therapeutic use; D012307:Risk Factors; D014376:Tuberculosis / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology / Q000276:immunology / Q000517:prevention & control; D032581:Tuberculosis Vaccines / Q000008:administration & dosage; D018088:Tuberculosis, Multidrug-Resistant / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology
chemical_list: D000995:Antitubercular Agents; D001500:BCG Vaccine; D032581:Tuberculosis Vaccines; D007538:Isoniazid; D012293:Rifampin